Pharmaceutical Industry Information Portal

HomeNews

News

Sputnik V vaccine approved for use in Chile

Thus Sputnik V is now approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.

EAEU GMP Certificate issued to Pharmasyntez

The Pharmasyntez Group of Companies also was one of the first in Russia to be granted a Marketing Authorization under the EAEU rules.

Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility

The 67,000-square-foot facility, located on Thermo Fisher's Carlsbad campus, is part of an investment strategy to ensure customers can reliably meet growing global demand for cell and gene therapies and vaccines.

Sputnik V vaccine against coronavirus authorized in Nigeria

Total population of all countries where Sputnik V is approved for use now exceeds 3.7 billion people, which is nearly half of the global population.

Rapid growth characterizes production of china’s vaccines

More than 1.4 billion doses of vaccines have been administered in China, and the country has provided over 500 million doses of vaccines overseas to assist in the global fight against the pandemic.

Russia wants to take down barriers for global production, distribution of vaccines

Russia actively fosters localization of its vaccine production abroad, which is based on technology transfer, while agreements were inked with several foreign companies.
spot_img

Expert Articles

spot_img